|
Duke Center for Human Genetics
The Center for Human Genetics (CHG) at Duke University Medical Center has actively recruited families for genetic studies in ET since 2000. Currently, we are not enrolling new families. However, the study is still active and once we are ready to resume recruitment of new study participants, we will post a notice on the TAN website. If you have any questions, please feel free to contact:
Trace Touch Screen Study
The Trace Center at the University of Wisconsin-Madison is looking for individuals who have movement disorders of their arms or hands to participate in a study for evaluating usability of information technology, If you would like to help the Trace Center in making information technology devices that are more accessible, please contact Bob Meyer at 608-263-3827 or send an email to: trace@wisc.edu.
Riboflavin Study
Dr. Esther Baldinger and Long Island Hospital College in Brooklyn, New York are recruiting essential tremor patients for a follow-up double blind study to further assess the effectiveness of Riboflavin for the treatment of ET. This study will evaluate patients four times: At baseline, with no Riboflavin treatment and then every six weeks on three different doses of Riboflavin, one of which will be low and will act as the placebo phase. Neither the patient or the doctor will know the order in which the doses will be given. Patients must be able to travel to Brooklyn, New York to participate. Any person willing to participate in this study should contact Dr. Baldinger at (718) 232-1570.
Writer's cramp: therapeutics perspectives
The use of splints can bring new results for the motor recovery of writer's cramp. Flavia Quadros Boisson Waissman, RPT, and Joćo Santos Pereira, MD, conducted the State University of Rio de Janeiro Study in two phases to gain a better understanding of the therapeutics perspectives of writer's cramp - focal dystonia.
| 
